US Federal 2025-2026 Regular Session

US Federal Senate Bill SB3200

Introduced
 
Introduced
11/19/25  

Caption

License Monopoly Prevention Act of 2025

Summary

The License Monopoly Prevention Act of 2025 would amend the Export Control Reform Act of 2018 to require the Bureau of Industry and Security (BIS) to conduct a competitive market review before issuing certain export, reexport, or in-country transfer licenses for emerging and foundational technologies. The review is intended to determine whether a requested authorization would effectively give a single applicant the sole license for a particular technology, end user, or end use. If more than one application exists, BIS could issue the license only if the technologies are sufficiently different to be treated as separate technologies for licensing purposes. The bill also requires BIS to consult with the Commerce Department’s International Trade Administration during the review and to certify the relevant congressional committees before issuing a sole license. After a sole license has been issued, BIS would generally be required to approve later applications for the same technology unless a new, unique risk or concern arises. The bill’s findings emphasize concerns that monopoly licenses can distort markets, create perceptions of favoritism, and undermine U.S. export control credibility and security policy.

Impact

If enacted, the bill would add a new procedural requirement to section 1758(b)(3) of the Export Control Reform Act of 2018, changing how BIS evaluates licenses for sensitive technologies. It would affect exporters, reexporters, and parties seeking in-country transfers of emerging and foundational technologies, while also increasing the role of the International Trade Administration and congressional oversight in the licensing process. The measure is aimed at preventing exclusive licensing arrangements that could create de facto monopolies for certain foreign end users or uses.

Sentiment

The bill appears to reflect a bipartisan concern about fairness and market distortion in export licensing, as shown by its introduction by Senator Scott and Senator Warren. Its tone is reform-oriented rather than deregulatory or expansionary, and the findings frame the issue as both an economic and national security problem. No committee debate or recorded votes are available in the provided materials, so the overall sentiment can only be inferred from the bill’s text and sponsorship.

Contention

The main point of contention is likely to be whether adding a competitive market review will improve fairness without slowing or complicating export-control decisions. Supporters would likely argue that BIS should avoid granting exclusive licenses that distort competition or appear to favor one company over another. Potential critics may worry that the new review and certification requirements could add bureaucracy, delay licensing decisions, or reduce flexibility in managing sensitive technology exports, especially where national security or foreign policy considerations require rapid action.

Companion Bills

No companion bills found.

Previously Filed As

US HB3016

Combatting Hospital Monopolies Act

US HB974

Electricity and Gas - Retail Supply (Freedom From Monopolies Act)

US HB0974

Electricity and Gas - Retail Supply (Freedom From Monopolies Act)

US HB8289

BIS Licensing Efficiency Act of 2026

US HR14

Relative to litigation concerning healthcare monopolies.

US HB0974

Electricity and Gas - Retail Supply (Freedom From Monopolies Act)

US SB3150

GAIN AI Act of 2025 Guaranteeing Access and Innovation for National Artificial Intelligence Act of 2025

US SB3374

SAFE Chips Act of 2025 Secure and Feasible Exports of Chips Act of 2025

US HB5885

GAIN AI Act of 2025 Guaranteeing Access and Innovation for National Artificial Intelligence Act of 2025

US HB8285

Protecting American Competition Act of 2026

Similar Bills

No similar bills found.